Familial hyperthyroidism due to mutations in TSH receptor: genes and variants
Explore variant evidence for Familial hyperthyroidism due to mutations in TSH receptor across 1 analyzed protein (TSHR). Linked ClinVar records include 18 pathogenic or likely pathogenic variants, 11 variants of uncertain significance and 10 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial hyperthyroidism due to mutations in TSH receptor
TSHR: Thyrotropin receptor
TSH signaling through this pathway drives thyroid-hormone synthesis, iodine handling, and thyroid growth. Activating variants can cause autonomous hyperthyroidism, whereas loss-of-function variants can cause TSH resistance and congenital hypothyroidism.
18 ClinVar pathogenic / likely pathogenic and 21 uncertain variants in TSHR have source records linked to Familial hyperthyroidism due to mutations in TSH receptor. Association strength is not clinical gene validity.
Where Familial hyperthyroidism due to mutations in TSH receptor variants cluster
- TSHR Transmembrane (positions 626–649): 4 of 18 ClinVar pathogenic / likely pathogenic variants, 7.1× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Familial hyperthyroidism due to mutations in TSH receptor
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| TSHR C390W | 390 | Extracellular | Pathogenic / likely pathogenic (★★★★) |
| TSHR Q90P | 90 | Extracellular | Pathogenic / likely pathogenic (★★) |
| TSHR P162A | 162 | LRR 3 | Pathogenic / likely pathogenic (★★) |
| TSHR F631V | 631 | Transmembrane | Pathogenic / likely pathogenic (★) |
| TSHR L252P | 252 | LRR 7 | Pathogenic / likely pathogenic (★) |
| TSHR V689G | 689 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| TSHR L629F | 629 | Transmembrane | Pathogenic / likely pathogenic (★) |
| TSHR P162L | 162 | LRR 3 | Pathogenic / likely pathogenic (★) |
| TSHR M453T | 453 | Transmembrane | Pathogenic / likely pathogenic (★) |
| TSHR R528S | 528 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| TSHR V656I | 656 | Extracellular | Pathogenic / likely pathogenic (★) |
| TSHR F631L | 631 | Transmembrane | Pathogenic / likely pathogenic |
| TSHR S281N | 281 | Extracellular | Pathogenic / likely pathogenic |
| TSHR G431S | 431 | Transmembrane | Pathogenic / likely pathogenic |
| TSHR V509A | 509 | Transmembrane | Pathogenic / likely pathogenic |
| TSHR P639S | 639 | Transmembrane | Pathogenic / likely pathogenic |
| TSHR C672Y | 672 | Transmembrane | Pathogenic / likely pathogenic |
| TSHR G132R | 132 | LRR 2 | Pathogenic / likely pathogenic |
Which prediction tools work for Familial hyperthyroidism due to mutations in TSH receptor
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 88 out of 100
- CATVariant: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 71 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Hypothyroidism due to TSH receptor mutations also has ClinVar records linked to TSHR variants; they fall mostly in different places as the Familial hyperthyroidism due to mutations in TSH receptor variants (24 pathogenic / likely pathogenic).
- Familial gestational hyperthyroidism also has ClinVar records linked to TSHR variants; they fall mostly in different places as the Familial hyperthyroidism due to mutations in TSH receptor variants (13 pathogenic / likely pathogenic).
- Thyroid adenoma, hyperfunctioning, somatic also has ClinVar records linked to TSHR variants; they fall mostly in different places as the Familial hyperthyroidism due to mutations in TSH receptor variants (5 pathogenic / likely pathogenic).
- Ovarian cancer also has ClinVar records linked to TSHR variants; they fall partly in the same places as the Familial hyperthyroidism due to mutations in TSH receptor variants (4 pathogenic / likely pathogenic).
Diseases related to Familial hyperthyroidism due to mutations in TSH receptor
- Ovarian cancer, also linked to TSHR
- Hypothyroidism due to TSH receptor mutations, also linked to TSHR
- Familial gestational hyperthyroidism, also linked to TSHR
- Hyperthyroidism, also linked to TSHR
- Hypothyroidism, also linked to TSHR
- Thyroid adenoma, hyperfunctioning, somatic, also linked to TSHR
Frequently asked questions
Which genes have records linked to Familial hyperthyroidism due to mutations in TSH receptor?
This view contains 1 analyzed proteins: TSHR. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 18 pathogenic or likely pathogenic variants, 11 variants of uncertain significance and 10 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 54 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center